Financhill
Back

Mirum Pharmaceuticals Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
69

MIRM
Mirum Pharmaceuticals

Last Price:
41.83
Seasonality Move:
33.22%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Mirum Pharmaceuticals Price Quote

$41.83
+1.11 (+2.73%)
(Updated: November 6, 2024 at 1:40 PM ET)

Mirum Pharmaceuticals Key Stats

Buy
69
Mirum Pharmaceuticals (MIRM) is a Buy

Day range:
$38.16 - $41.00
52-week range:
$23.14 - $45.23
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.00
P/B ratio:
8.48%

Volume:
271.7K
Avg. volume:
298.9K
1-year change:
35.73%
Market cap:
$1.9B
Revenue:
$186.4M
EPS:
$-2.34

How Much Does Mirum Pharmaceuticals Make?

Is Mirum Pharmaceuticals Growing As A Company?

  • What Is Mirum Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.08%
  • What Is Mirum Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Mirum Pharmaceuticals Stock Price Performance

What Is Mirum Pharmaceuticals 52-Week High & Low?

Mirum Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Mirum Pharmaceuticals?

Is Mirum Pharmaceuticals Cash Flow Positive?

  • What Is MIRM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$23.4M
  • What Is Mirum Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $217.4M
  • What Is Mirum Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$257.5M

Mirum Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    MIRM return on invested capital is -21.06%
  • What Is Mirum Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -17.88%
  • What Is MIRM Return On Equity?
    ROE is a measure of profitability and is -51.5%

Mirum Pharmaceuticals Earnings Date & Stock Price

Mirum Pharmaceuticals Competitors

Mirum Pharmaceuticals Dividend Yield

Mirum Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -12.25%
Revenue: 107.68% 3.72%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 59.45
Upside from Last Price: 46.01%

Major Shareholders

  • How many MIRM shares are owned by institutional investors?
    68.2M MIRM shares are owned by institutional investors
  • How many MIRM shares are owned by insiders?
    415.9K MIRM shares are owned by insiders